Avenue Therapeutics, Inc.
(NASDAQ : ATXI)

( )
ATXI After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc.
-0.14%42.140.9%$1149.17m
LLYEli Lilly and Company
0.06%122.731.0%$1042.43m
JNJJohnson & Johnson
-0.68%135.420.6%$983.33m
MRKMerck & Co., Inc.
0.50%79.830.6%$948.36m
BMYBristol-Myers Squibb Company
-2.24%50.151.4%$769.39m
ABBVAbbVie, Inc.
-1.56%78.742.2%$656.42m
AZNAstraZeneca PLC Sponsored ADR
-0.25%40.431.3%$193.16m
NVSNovartis AG Sponsored ADR
-0.25%90.510.2%$186.90m
GSKGlaxoSmithKline plc Sponsored ADR
-0.55%40.540.2%$136.57m
NVONovo Nordisk A/S Sponsored ADR Class B
-0.08%49.660.1%$70.22m
SNYSanofi Sponsored ADR
-1.95%41.330.2%$36.85m
LCILannett Company, Inc.
-4.69%9.3437.0%$16.40m
AKTXAkari Therapeutics Plc Sponsored ADR
1.07%1.891.7%$0.06m
EPIXESSA Pharma Inc
-5.33%3.550.1%$0.04m

Company Profile

Avenue Therapeutics, Inc. operates as a pharmaceutical company. It engages in acquiring, licensing, developing, and commercializing products for use in the intensive care hospital setting. The company was founded on February 9, 2015 and is headquartered in New York, NY.